Localization of Oxidized Low-Density Lipoprotein and Its Relation to Plaque Morphology in Human Coronary Artery

Uchida, Yasumi; Maezawa, Yuko; Uchida, Yasuto; Hiruta, Nobuyuki; Shimoyama, Ei; Kawai, Seiji
February 2013
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
Academic Journal
Objectives: Oxidized low-density lipoprotein (oxLDL) plays a key role in the formation of atherosclerotic plaques. However, its localization in human coronary arterial wall is not well understood. The present study was performed to visualize deposition sites and patterns of native oxLDL and their relation to plaque morphology in human coronary artery. Methods: Evans blue dye (EB) elicits a violet fluorescence by excitation at 345-nm and emission at 420-nm, and a reddish-brown fluorescence by excitation at 470-nm and emission at 515-nm characteristic of oxLDL only. Therefore, native oxLDL in excised human coronary artery were investigated by color fluorescent microscopy (CFM) using EB as a biomarker. Results: (1) By luminal surface scan with CFM, the % incidence of oxLDL in 38 normal segments, 41 white plaques and 32 yellow plaques that were classified by conventional angioscopy, was respectively 26, 44 and 94, indicating significantly (p<0.05) higher incidence in the latter than the former two groups. Distribution pattern was classified as patchy, diffuse and web-like. Web-like pattern was observed only in yellow plaques with necrotic core. (2) By transected surface scan, oxLDL deposited within superficial layer in normal segments and diffusely within both superficial and deep layers in white and yellow plaques. In yellow plaques with necrotic core, oxLDL deposited not only in the marginal zone of the necrotic core but also in the fibrous cap. Conclusion: Taken into consideration of the well-known process of coronary plaque growth, the results suggest that oxLDL begins to deposit in human coronary artery wall before plaque formation and increasingly deposits with plaque growth, exhibiting different deposition sites and patterns depending on morphological changes.


Related Articles

  • Statin therapy reduces first event severity.  // Geriatrics;May2006, Vol. 61 Issue 5, p9 

    Discusses research being done on the role of statins in reversing plaque progression and reducing the chances of a more serious initial presentation of coronary symptoms. Reference to a study by Alan Go et al in a 2006 issue of "Annals of Internal Medicine"; Effects of statins on lowering low...

  • Atherosclerotic Cardiovascular Disease Risk and Evidence-based Management of Cholesterol. Roy, Satyajeet // North American Journal of Medical Sciences;May2014, Vol. 6 Issue 5, p191 

    An elevated level of low-density lipoprotein cholesterol is directly associated with development of atherosclerotic cardiovascular disease, which may present as coronary heart disease, stroke, and peripheral arterial disease. The new cholesterol management guidelines from the American College of...

  • Statins Improve Human Coronary Atherosclerotic Plaque Morphology. Reilly, Stephanie D.; Litovsky, Silvio H.; Steinkampf, Michael P.; Caulfield, James B. // Texas Heart Institute Journal;2008, Vol. 35 Issue 2, p99 

    Statin treatment markedly reduces the incidence of acute coronary events in patients with coronary atherosclerosis. Although imaging studies have indirectly shown the beneficial effects of statins on plaque morphology, there has to our knowledge been no reported histologic comparison of the...

  • LOX-1, a new marker of risk and prognosis in coronary artery disease? Lubrano, Valter; Balzan, Silvana // Molecular & Cellular Biochemistry;Nov2013, Vol. 383 Issue 1/2, p223 

    The development of atherosclerosis is caused by the accumulation of lipid, inflammatory cytokine production, and the large amount of inflammatory cells in the arterial wall. It is now established that the presence of oxidized low-density lipoproteins (ox-LDL) has an important role in the...

  • Lipoprotein(a) Is the Best Single Marker in Assessing Unstable Angina Pectoris. Djordjević, Vidosava B.; Ćosić, Vladan; Stojanović, Ivana; Kundalić, Slavica; Zvezdanović, Lilika; Deljanin-Ilić, Marina; Vlahović, Predrag; Popović, Lidija // Cardiology Research & Practice;2011, p1 

    This study evaluated whether statin therapy changed a diagnostic validity of lipid and inflammatory markers in ischemic heart disease (IHD) patients. Levels of lipids, lipoproteins, apolipoproteins, inflammatory markers, and atherogenic indexes were determined in 49 apparently healthy men and...

  • Molecular Imaging of Low-density Lipoprotein in Human Coronary Plaques by Color Fluorescent Angioscopy and Microscopy. Uchida, Yasumi; Maezawa, Yuko; Uchida, Yasuto; Hiruta, Nobuyuki; Shimoyama, Ei // PLoS ONE;Nov2012, Vol. 7 Issue 11, Special section p1 

    Objectives: Low-density lipoprotein (LDL) is an important risk factor for coronary artery disease. However, its localization in human coronary plaques is not well understood. The present study was performed to visualize LDL in human coronary artery wall. Methods: (1) The fluorescence...

  • OxLDL- and HSP-60 antigen-specific CD8+ T lymphocytes are detectable in the peripheral blood of patients suffering from coronary artery disease. Ghio, M.; Fabbi, P.; Contini, P.; Fedele, M.; Brunelli, C.; Indiveri, F.; Barsotti, A. // Clinical & Experimental Medicine;Nov2013, Vol. 13 Issue 4, p251 

    Abstracts: Inflammatory and immunologic mechanisms are important for the initiation and the progression of atherosclerotic lesions. OxLDL and HSP-60 antigens are involved in the pathogenesis of atherosclerotic disease by triggering immune cells within the plaques. Through the MHC pentamer...

  • Coffee consumption and coronary artery calcium in young and middle-aged asymptomatic adults. Yuni Choi; Yoosoo Chang; Seungho Ryu; Juhee Cho; Rampal, Sanjay; Yiyi Zhang; Jiin Ahn; Lima, Joao A. C.; Hocheol Shin; Guallar, Eliseo // Heart;May2015, Vol. 101 Issue 9, p686 

    Objective To investigate the association between regular coffee consumption and the prevalence of coronary artery calcium (CAC) in a large sample of young and middle-aged asymptomatic men and women. Methods This cross-sectional study included 25 138 men and women (mean age 41.3 years) without...

  • P214 The study of anti-oxLDL autoantibody biomarker on the prevention of ACS. Sumiya, TS; Zorigoo, SH; Odkhuu, E; Munkhzol, M // Cardiovascular Research;Jul2014, Vol. 103 Issue suppl_1, pS38 

    Background: The disease is caused by the thrombogenesis resulting from the rupture of a coronary atherosclerosis plaque.As some researchers believe the main cause of the coronary atherosclerosis plaque rupture is the connection of oxLDL autoantigen contained in the atheroma plaques with the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics